These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 25323007
21. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab. Wanner K, Hipp S, Oelsner M, Ringshausen I, Bogner C, Peschel C, Decker T. Br J Haematol; 2006 Sep; 134(5):475-84. PubMed ID: 16856892 [Abstract] [Full Text] [Related]
25. Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line. Han J, Tang Y, Zhong M, Wu W. Mol Med Rep; 2019 Dec; 20(6):5064-5074. PubMed ID: 31638226 [Abstract] [Full Text] [Related]
30. Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma. Uddin S, Bu R, Ahmed M, Hussain AR, Ajarim D, Al-Dayel F, Bavi P, Al-kuraya KS. Leuk Lymphoma; 2010 Jul; 51(7):1305-14. PubMed ID: 20443680 [Abstract] [Full Text] [Related]
32. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1. Zang C, Eucker J, Liu H, Müller A, Possinger K, Scholz CW. Cancer Lett; 2013 Oct 10; 339(2):288-97. PubMed ID: 23200668 [Abstract] [Full Text] [Related]